ARC102 Investigational CD3-engaging antibody in IND-enabling development for ovarian, pancreatic, and endometrial cancers; its tumor target remains undisclosed.
Visit productCosigns Received
Be the first Cosign
Put your name behind ARC102.
Add it to your Products I use list and share why you use it.